06/30/2022
We are proud to announce Center for Medicare and Medicaid Services (CMS) coverage for participants in the GUARDIAN™ clinical trial, a multi-center randomized controlled clinical study evaluating the safety and efficacy of the Protect PNS neurostimulator medical device, as compared to traditional pharmaceutical medical management for the treatment for overactive bladder (OAB)
https://www.prnewswire.com/news-releases/uro-medical-wireless-microstimulator-secures-cms-coverage-of-2nd-clinical-trial-for-treatment-of-overactive-bladder-301578350.html
/PRNewswire/ -- Uro Medical Corporation, a privately-held urology-focused medical device company engaged in the development, manufacture, and commercialization...